Gaucher’s Disease, a rare genetic disorder resulting from a deficiency of the enzyme glucocerebrosidase, has significant implications for affected individuals and their families. As the understanding of this disease evolves, so does the market landscape for treatments and drugs designed to manage Gaucher's Disease. This article provides an in-depth analysis of the Gaucher’s Disease...